Global Obesity Treatment Market

Obesity Treatment Market size is expected to reach nearly USD 29.46 Bn. by 2032 with the CAGR of 8.45% during the forecast period.

Obesity is a disorder characterized by an extreme amount of body fat. The most commonly used principles to assess the existence and the severity of obesity are waist circumference, body mass index, waist-to-height ratio, and the occurrence of the health conditions caused or degenerated by obesity.To know about the Research Methodology :- Request Free Sample Report

Global obesity has increased more than double in the last four decades. Obesity is the second foremost preventable causes of death globally. Treatment of obesity mostly incorporates two-step processes that are management and assessment. Obesity assessment contains the determination of the obesity level and obesity management includes overall maintenance of body weight including the organized weight loss programs.

The MMR report contains a detailed study of factors that will drive and restrain the growth of the obesity treatment market. Such as, the global market for obesity treatment is driven by a number of factors like technological advancements in the medical industry, easy obtainability of weight management treatments commercially and many government initiatives concerning overweight issues. As per the world health organization (WHO), about 13% of the global population is categorized as ‘obese’. Weights regain after obesity treatments and high prices are the major hindrances faced by the obesity treatment market globally.

North America obesity treatment market was valued USD xx Mn. in 2025 and is expected to reach a value of USD xx Mn. by 2032, with a CAGR of xx60% during the forecast period. The USA holds major share thanks to the growing obese population influenced by the changing lifestyles in various economies and the increasing spending on R&D and healthcare industry.

Europe holds the second largest share in the obesity treatment market and it is expected to grow at a CAGR of xx % during 2026-2032. Europe aids from the availability of research funds, mounting obese population, and growing adoption of bariatric surgeries.

The MMR report will also provide an accurate prediction of the contribution of the various segments to the growth of the obesity treatment market size. By surgery, the endoscopic procedures segment expected to grow at the highest xx% CAGR during the forecast period. This is because of the falling incidences of post-operative infections that stem from non-invasive & invasive procedures.

Major players in the obesity treatment market have taken several strategic measures, such as facility expansions and partnerships. Such as, in 2022, Boehringer Ingelheim Company has cooperated with Gubra group to develop new poly-agonist peptides for the obesity treatment. This will be their second cooperation, which will combine Gubra’s know-how in the synthesis, design, in vivo testing of therapeutic peptides and pharmaceutical description with Boehringer Ingelheim Company in R&D of advanced medicines for cardio metabolic diseases.

The objective of the report is to present a comprehensive analysis of the Global Obesity Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Obesity Treatment Market dynamics, structure by analyzing the market segments and projects the Global Obesity Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Obesity Treatment Market make the report investor’s guide.

Recent Industry Developments (2025–2026)

Obesity Treatment Market Scope: Inquire before buying

Obesity Treatment Market, By Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

key players / competitors profiles covered in the Obesity Treatment Market report in strategic perspective

Olympus Corporation
F. Hoffmann-La Roche, Ltd.
Cousin Biotech
VIVUS, Inc.
Allergan
Johnson & Johnson Services, Inc.
Arena Pharmaceuticals, Inc.
Orexigen Therapeutics, Inc.
Medtronic
USGI Medical, Inc.
Covidien plc
Mediflex Surgical Products
EnteroMedics, Inc.
GlaxoSmithKline plc
Pfizer Inc.
AstraZeneca PLC
Sanofi S.A.
Boehringer Ingelheim International GmbH
Altimmune, Inc.
Allurion Technologies
Amgen Inc.
Rhythm Pharmaceuticals, Inc.
Reshape Lifesciences Inc.
Viking Therapeutics, Inc.
Structure Therapeutics (U.S.)
Zealand Pharma A/S
Novo Nordisk A/S